Malignancy
Conditions
Interventions
Study period will be seven consecutive days. Five consecutive days of iEat and before-and-after one day of regular diet. iEat will be provided only lunch every day. Breakfast and dinner will be regul
Sponsors
Minoh City Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients who have given voluntary written informed consent 2)Patients aged 20 years and older at the time of informed consent 3)Male or female patients 4)Do not consider presence or absence of gastrointestinal stent placement 5)Do not consider presence or absence of chemotherapy
Exclusion criteria
Exclusion criteria: 1)Patients who cannot be communicated with the investigator, etc. due to disturbance of consciousness and dementia, etc. 2)Patients with food allergy 3)Patients with concomitantly-used tube feeding 4)Patients judged to be inappropriate for the study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate safety (digestive symptoms) during the trial (in principal 7 days). Outcomes are abdominal pain, diarrhea, abdominal fullness, nausea, vomiting. Outcomes will be graded according to Common Terminology Criteria for Adverse Events v.4.0 JCOG version (Abbr. CTCAE v4.0 JCOG) [Equiv. CTCAE v4.02/MedRA/J v12.1 Published February 1, 2010] | — |
Secondary
| Measure | Time frame |
|---|---|
| Feeding rate Questionnaire about satisfaction | — |
Countries
Japan
Outcome results
None listed